Evidence map›Paper›PMID 37990912›Full record

ArticleJournal of clinical and experimental neuropsychology2023

Use of the Spanish English Neuropsychological Assessment Scale in older adult Latines and those at risk for autosomal dominant Alzheimer's disease.

Kayla N Tureson, Christopher R Beam, Luis D Medina, Freddi Segal-Gidan, Lina M D'Orazio, Helena Chui, Mina Torres, Rohit Varma, John M Ringman

Abstract read
In one paragraph

Article in Journal of clinical and experimental neuropsychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kayla N TuresonAlzheimer's Disease Research Center, Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Christopher R BeamDepartment of Psychology, University of Southern California, Los Angeles, CA, USA.
Luis D MedinaDepartment of Psychology, University of Houston, Houston, TX, USA.
Freddi Segal-GidanAlzheimer's Disease Research Center, Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Lina M D'OrazioAlzheimer's Disease Research Center, Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Helena ChuiAlzheimer's Disease Research Center, Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.
Mina TorresCHA Hollywood Presbyterian Medical Center, Southern California Eye Institute, Los Angeles, CA, USA.
Rohit VarmaCHA Hollywood Presbyterian Medical Center, Southern California Eye Institute, Los Angeles, CA, USA.
John M RingmanAlzheimer's Disease Research Center, Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA.

Funding

LOS ANGELES LATINO EYE STUDYU10EY011753 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI VARMA, ROHIT · 1998 to 2014
$35.6M
USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Hussein N Yassine · 2020 to 2026
$27.8M
Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer’s DiseaseR01AG062007 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RINGMAN, JOHN M · 2019 to 2023
$4.1M
The structural and functional connectome across Alzheimer's disease subtypesU01AG051218 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RINGMAN, JOHN M · 2015 to 2018
$3.6M
Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, MexicoR01AG069013 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RINGMAN, JOHN M · 2020 to 2024
$3.3M
FMRI in Pre-Symptomatic PS1-related Alzheimer's DiseaseK08AG022228 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RINGMAN, JOHN M · 2003 to 2005
$481k
Environmental Moderation of Genetic Influences on Dementia Risk in Mexican Older AdultsF31AG077889 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TURESON, KAYLA · 2023 to 2024
$95k
NEI NIH HHS U10 EY011753NIA NIH HHS F31 AG077889NIA NIH HHS K08 AG022228NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG062007NIA NIH HHS R01 AG069013NIA NIH HHS U01 AG051218
6 · The paper itself

Abstract

objectiveThe Spanish English Neuropsychological Assessment Scale (SENAS) is a cognitive battery with English and Spanish versions for use with persons for whom either language is predominant. Few studies have examined its utility outside the normative sample. The current study examined SENAS performance in samples of older adult Latines and Latines with or at risk for autosomal dominant Alzheimer's disease (ADAD) mutations.

methodThe SENAS was administered to 202 older adults from the Los Angeles Latino Eye Study (LALES) and 29 adults with (carriers) or without (non-carriers) mutations causing ADAD. We examined associations between SENAS, age, education, and language (LALES) and between SENAS, estimated years from familial age of dementia diagnosis, education, language, and acculturation (ADAD). Partial correlations were used to examine differences in correlational strength between estimated years from familial age of dementia diagnosis and SENAS scores among ADAD carriers compared to chronological age and SENAS in the LALES sample. Exploratory t-tests were performed to examine SENAS performance differences between ADAD carriers and non-carriers.

resultsIn an older adult sample (LALES), increased age correlated with worse verbal delayed recall; English fluency and higher education correlated with better naming and visuospatial subtest performance. Among ADAD carriers, verbal and nonverbal delayed recall and object naming subtest performance worsened as they approached their familial age of dementia diagnosis. English fluency and higher U.S.-acculturation were related to better SENAS performance among carriers and non-carriers. Tests of verbal delayed recall and object naming best distinguished ADAD carriers from their familial non-carrier counterparts.

conclusionsVerbal delayed recall and object naming measures appear to be most sensitive to age-related changes in older adult samples and mutation-related changes in distinguishing ADAD carriers from non-carriers. Future research should examine the sensitivity of SENAS in other samples, such as larger samples of symptomatic ADAD carriers and other AD subtypes.

Indexed as

Alzheimer DiseaseAgedHispanic or LatinoHumansLanguageMutationNeuropsychological TestscognitiondementiaLatinoneurodegenerative diseaseneuropsychology

Identifiers

PMID37990912
PMCPMC10926998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.